Blincyto registered with KRW 2.48 million

Published: 2016-09-27 14:23:09

Updated: 2016-09-27 14:23:09

An acute lymphoblastic leukemia treatment, Blincyto(blinatumomab) and a cell treatment for burn, Keraheal-Allo(cultured allogenic keratinocytes, kaloderm) will be newly registered in the drug insurance benefit list.

Upper limit prices of three products including CKD Gliatilin Inj(choline alfoscerate) will be reduced by 30% due to the impact of generic registrations.

According to the Ministr...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.